443 related articles for article (PubMed ID: 26938946)
1. An Essential Role of the Avidity of T-Cell Receptor in Differentiation of Self-Antigen-reactive CD8+ T Cells.
Kondo K; Fujiki F; Nakajima H; Yatsukawa E; Morimoto S; Tatsumi N; Nishida S; Nakata J; Oka Y; Tsuboi A; Hosen N; Oji Y; Sugiyama H
J Immunother; 2016 Apr; 39(3):127-39. PubMed ID: 26938946
[TBL] [Abstract][Full Text] [Related]
2. Recognition of a natural WT1 epitope by a modified WT1 peptide-specific T-cell receptor.
Tamanaka T; Oka Y; Fujiki F; Tsuboi A; Katsuhara A; Nakajima H; Hosen N; Nishida S; Lin YH; Tachino S; Akatsuka Y; Kuzushima K; Oji Y; Kumanogoh A; Sugiyama H
Anticancer Res; 2012 Dec; 32(12):5201-9. PubMed ID: 23225417
[TBL] [Abstract][Full Text] [Related]
3. A High-avidity WT1-reactive T-Cell Receptor Mediates Recognition of Peptide and Processed Antigen but not Naturally Occurring WT1-positive Tumor Cells.
Jaigirdar A; Rosenberg SA; Parkhurst M
J Immunother; 2016 Apr; 39(3):105-16. PubMed ID: 26938944
[TBL] [Abstract][Full Text] [Related]
4. Peripheral "CD8 tuning" dynamically modulates the size and responsiveness of an antigen-specific T cell pool in vivo.
Maile R; Siler CA; Kerry SE; Midkiff KE; Collins EJ; Frelinger JA
J Immunol; 2005 Jan; 174(2):619-27. PubMed ID: 15634879
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of two T cell receptors, TcR1 and TcR2, on chicken lymphocytes.
Chen CL; Cihak J; Lösch U; Cooper MD
Eur J Immunol; 1988 Apr; 18(4):539-43. PubMed ID: 3259183
[TBL] [Abstract][Full Text] [Related]
6. Comparison of vaccine-induced effector CD8 T cell responses directed against self- and non-self-tumor antigens: implications for cancer immunotherapy.
Pedersen SR; Sørensen MR; Buus S; Christensen JP; Thomsen AR
J Immunol; 2013 Oct; 191(7):3955-67. PubMed ID: 24018273
[TBL] [Abstract][Full Text] [Related]
7. Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety.
Ochi T; Fujiwara H; Okamoto S; An J; Nagai K; Shirakata T; Mineno J; Kuzushima K; Shiku H; Yasukawa M
Blood; 2011 Aug; 118(6):1495-503. PubMed ID: 21673345
[TBL] [Abstract][Full Text] [Related]
8. T cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversity.
Sandberg JK; Franksson L; Sundbäck J; Michaelsson J; Petersson M; Achour A; Wallin RP; Sherman NE; Bergman T; Jörnvall H; Hunt DF; Kiessling R; Kärre K
J Immunol; 2000 Jul; 165(1):25-33. PubMed ID: 10861031
[TBL] [Abstract][Full Text] [Related]
9. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
Duong MN; Erdes E; Hebeisen M; Rufer N
J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
[TBL] [Abstract][Full Text] [Related]
10. Specific roles of each TCR hemichain in generating functional chain-centric TCR.
Nakatsugawa M; Yamashita Y; Ochi T; Tanaka S; Chamoto K; Guo T; Butler MO; Hirano N
J Immunol; 2015 Apr; 194(7):3487-500. PubMed ID: 25710913
[TBL] [Abstract][Full Text] [Related]
11. Hierarchies in cytokine expression profiles for acute and resolving influenza virus-specific CD8+ T cell responses: correlation of cytokine profile and TCR avidity.
La Gruta NL; Turner SJ; Doherty PC
J Immunol; 2004 May; 172(9):5553-60. PubMed ID: 15100298
[TBL] [Abstract][Full Text] [Related]
12. The fate of low affinity tumor-specific CD8+ T cells in tumor-bearing mice.
Lyman MA; Nugent CT; Marquardt KL; Biggs JA; Pamer EG; Sherman LA
J Immunol; 2005 Mar; 174(5):2563-72. PubMed ID: 15728462
[TBL] [Abstract][Full Text] [Related]
13. A third sublineage of avian T cells can be identified with a T cell receptor-3-specific antibody.
Char D; Sanchez P; Chen CL; Bucy RP; Cooper MD
J Immunol; 1990 Dec; 145(11):3547-55. PubMed ID: 2123221
[TBL] [Abstract][Full Text] [Related]
14. A low affinity TCR ligand restores positive selection of CD8+ T cells in vivo.
Stefanski HE; Mayerova D; Jameson SC; Hogquist KA
J Immunol; 2001 Jun; 166(11):6602-7. PubMed ID: 11359813
[TBL] [Abstract][Full Text] [Related]
15. Homology between an alloantigen and a self MHC allele calibrates the avidity of the alloreactive T cell repertoire independent of TCR affinity.
Hornell TM; Myers N; Hansen TH; Connolly JM
J Immunol; 2003 May; 170(9):4506-14. PubMed ID: 12707327
[TBL] [Abstract][Full Text] [Related]
16. Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.
May RJ; Dao T; Pinilla-Ibarz J; Korontsvit T; Zakhaleva V; Zhang RH; Maslak P; Scheinberg DA
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4547-55. PubMed ID: 17671141
[TBL] [Abstract][Full Text] [Related]
17. High frequencies of less differentiated and more proliferative WT1-specific CD8+ T cells in bone marrow in tumor-bearing patients: an important role of bone marrow as a secondary lymphoid organ.
Murao A; Oka Y; Tsuboi A; Elisseeva OA; Tanaka-Harada Y; Fujiki F; Nakajima H; Nishida S; Hosen N; Shirakata T; Hashimoto N; Myoui A; Ueda T; Takeda Y; Osaki T; Enomoto T; Yoshikawa H; Kimura T; Oji Y; Kawase I; Sugiyama H
Cancer Sci; 2010 Apr; 101(4):848-54. PubMed ID: 20136847
[TBL] [Abstract][Full Text] [Related]
18. Generation of high-avidity, WT1-reactive CD8+ cytotoxic T cell clones with anti-leukemic activity by streptamer technology.
Tunger A; Wehner R; von Bonin M; Kühn D; Heidenreich F; Matko S; Nauerth M; Rücker-Braun E; Dietz S; Link CS; Eugster A; Odendahl M; Busch DH; Tonn T; Bonifacio E; Germeroth L; Schetelig J; Bachmann MP; Bornhäuser M; Schmitz M
Leuk Lymphoma; 2017 May; 58(5):1246-1249. PubMed ID: 27852136
[No Abstract] [Full Text] [Related]
19. Characterization of CD8+ T lymphocytes that persist after peripheral tolerance to a self antigen expressed in the pancreas.
Nugent CT; Morgan DJ; Biggs JA; Ko A; Pilip IM; Pamer EG; Sherman LA
J Immunol; 2000 Jan; 164(1):191-200. PubMed ID: 10605011
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a novel platform cell line for efficient and precise evaluation of T cell receptor functional avidity.
Morimoto S; Fujiki F; Kondo K; Nakajima H; Kobayashi Y; Inatome M; Aoyama N; Nishida Y; Tsuboi A; Oka Y; Nishida S; Nakata J; Hosen N; Oji Y; Sugiyama H
Oncotarget; 2018 Sep; 9(75):34132-34141. PubMed ID: 30344927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
